What you need to know about Johnson & Johnson’s 2021 first-quarter earnings
Check out this infographic breakdown of the company’s first-quarter 2021 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.
This morning, Johnson & Johnson shared its first-quarter performance.
For more than 130 years, the company has aimed to make people well at every age and every stage of life. Today, as the world’s largest and most broadly based healthcare company, with approximately 135,000 employees across the globe, the organization is striving to put a healthy mind, body and environment within reach of everyone, everywhere.
“Our strong first-quarter performance was primarily driven by above market growth in our pharmaceutical segment and continued recovery in our medical device unit,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We are more confident than ever in the resilience of our diversified portfolio and the unwavering commitment of our Johnson & Johnson colleagues to deliver life-enhancing medicines and products to patients and customers around the globe. We remain focused on creating long-term value for all our stakeholders and investing in innovation that helps to further our goal of changing the trajectory of health for humanity.”
For more details about the company’s 2021 first-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.
Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.